Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment.

Journal of viral hepatitis - 1 Nov 2017

Lok A S, Ganova-Raeva L, Cloonan Y, Punkova L, Lin H-H S, Lee W M, Ghany M G

Abstract excerpt

Antiviral drug resistance hepatitis B virus (HBV) variants (HBV-DR) occur spontaneously in chronic hepatitis B (CHB) patients and after exposure to nucleos(t)ide analogues (NUCs). We determined the prevalence of HBV-DR variants among participants of the Hepatitis B Research Network (HBRN) Cohort Study conducted at 21 sites in the United States (US) and Canada. Samples obtained from 1342 CHB participants aged...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to DNA, Viral

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Resistance, Viral

Share to Hepatitis B, Chronic

Share to Hepatitis B virus

Share to High-Throughput Nucleotide Sequencing

Share to North America

Share to Population Surveillance

Source

Open in PubMed Open full text

Identifiers

PMID: 28581155
DOI: 10.1111/jvh.12732
PMCID: PMC5638682

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prevalence of hepatitis B antiviral drug resistance variants in North American patients with chronic hepatitis B not receiving antiviral treatment.PMID 28581155Read ↗

Evaluation of Hepatitis B Virus Nucleos(t)ide Analogues Resistance mutations in Treatment-Naïve Patients: A Systematic Review and Meta-AnalysisSemantic proximity Read ↗

Immune Escape and Drug Resistance Mutations in Patients with Hepatitis B Virus Infection: Clinical and Epidemiological ImplicationsSemantic proximity Read ↗

Characteristics of adults in the hepatitis B research network in North America reflect their country of origin and hepatitis B virus genotype.Semantic proximity Read ↗

Viral resistance in hepatitis B: prevalence and management.Semantic proximity Read ↗

Prevalence of hepatitis B virus DNA polymerase mutations in treatment-naïve patients with chronic hepatitis B.Semantic proximity Read ↗

Genotyping of HBV and tracking of resistance mutations in treatment-naïve patients with chronic hepatitis BSemantic proximity Read ↗

Antiviral drug resistance and hepatitis B: a continuing public health problem.Semantic proximity Read ↗

Trends in hepatitis B virus resistance to nucleoside/nucleotide analogues in North China from 2009-2016: A retrospective study.Semantic proximity Read ↗

Prevalence of NS5B resistance-associated variants in treatment-naïve Asian patients with chronic hepatitis C.Semantic proximity Read ↗

Real-world evidence for nucleoside/nucleotide analogues in a 5-year multicentre study of antiviral-naive chronic hepatitis B patients in China: 52-week results.Semantic proximity Read ↗

Mutations in Pol gene of hepatitis B virus in patients with chronic hepatitis B before and after therapy with nucleoside/nucleotide analogues.Semantic proximity Read ↗

Early changes in quasispecies variant after antiviral therapy for chronic hepatitis B.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.